- www.liphag.com
- Business segment: Financial services
- Leo International Precision Health AG
- Am Klopferspitz 19
- 82152 Planegg/Martinsried
- Deutschland
- moc.gahpil@ri
Leo International Precision Health AG
Prof. Dr. Joshua Lo, CEO
About Leo International Precision Health
AI-Driven Precision Health Platform
Leo International Precision Health AG (LIPH) is a Frankfurt Stock Exchange-listed holding company building a global integrated AI-driven healthcare ecosystem. With a strategic focus on AI-driven precision healthcare assets across Biotech, MedTech, HealthTech and Healthcare Services, LIPH offers investors transparent access to the expanding Asian and global healthcare and life sciences market.
LIPH’s business model is built on scalability, innovation, and synergy. With focus on acquiring and developing attractive opportunities, enhancing their value and selectively spinning them off, the Company aims to increase shareholder value through asset reconfiguration, revenue growth, licensing and royalties.
The Company identifies, screens, and rigorously evaluates high-potential healthcare businesses across diagnostics, digital solutions, therapeutics, and personalized care, with a focus on building a strong and complementary portfolio. By maintaining an active operating role within its portfolio, LIPH supports the growth and development of promising healthcare businesses, creating value through innovation, collaboration, and durable growth.
What drives you?
Built on innovation, synergy, and scalability, we are advancing the future of precision healthcare. Our current portfolio spans diagnostics, digital solutions, therapeutics, and personalized care — including clinics and nutraceuticals — united by a shared commitment to improving patient outcomes. Together, they form the foundation of a global integrated, AI-driven healthcare ecosystem, unlocking data-driven synergies across the portfolio.
In response to rising demand from aging populations, escalating healthcare costs, and growing data fragmentation, we invest across biotech, medtech, healthtech, and healthcare services—covering the full precision healthcare continuum from discovery to patient care and enabling a more intelligent, efficient, and patient-centered healthcare system.
“The Innovation and Start-up Center Biotechnology IZB offers an exceptional environment where cutting-edge technology and entrepreneurial excellence generate strong synergies across the life sciences ecosystem. For LIPH, it is the ideal location to advance AI-enabled precision health and translate innovation into meaningful impact for patients and healthcare systems worldwide.”
Prof. Dr. Joshua Lo, CEO
